Advertisement
Organisation › Details
CORAT Consortium (DE)
The CORAT consortium was initiated by YUMAB founder Prof. Stefan Dübel (University of Braunschweig) and Prof. Gundram Jung (University of Tübingen) soon after the outbreak of Covid-19 in Germany. The consortium is comprised of multiple academic and industrial partners located in the Helmholtz Centre for Infectious Diseases (HZI). CORAT seeks to identify an effective treatment against Covid-19. *
Start | 2020-05-07 existent | |
Group | Unchained Labs Belgium | |
Industry | anti-infective drug | |
Person | Dübel, Stefan (TU Braunschweig 201912 Professor for Biotechnology) | |
Person 2 | Jung, Gundram (Univ Tübingen 201205 Professor at Institute of Immunology) | |
Region | Germany | |
City | n. a. | |
Address record changed: 2020-05-14 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Yumab GmbH. (5/7/20). "Press Release: Yumab Identifies Promising Candidate for Covid-19 Antibody Therapy". Braunschweig. | ||
Record changed: 2023-12-30 |
Advertisement
More documents for Unchained Labs Belgium
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top